Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Major Shareholder Fosun Pharmaceutical Shanghai Sells 1,300 Shares

Nature’s Sunshine Products, Inc. (NASDAQ:NATR) major shareholder Fosun Pharmaceutical Shanghai sold 1,300 shares of Nature’s Sunshine Products stock in a transaction that occurred on Monday, October 14th. The shares were sold at an average price of $13.12, for a total value of $17,056.00. Following the sale, the insider now directly owns 66,467 shares in the company, valued at approximately $872,047.04. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Fosun Pharmaceutical Shanghai also recently made the following trade(s):

• On Thursday, October 10th, Fosun Pharmaceutical Shanghai sold 3,000 shares of Nature’s Sunshine Products stock. The stock was sold at an average price of $13.39, for a total value of $40,170.00.
• On Tuesday, October 8th, Fosun Pharmaceutical Shanghai sold 1,800 shares of Nature’s Sunshine Products stock. The stock was sold at an average price of $13.13, for a total value of $23,634.00.
• On Tuesday, October 1st, Fosun Pharmaceutical Shanghai sold 1,399 shares of Nature’s Sunshine Products stock. The stock was sold at an average price of $13.54, for a total value of $18,942.46.

Nature’s Sunshine Products Stock Up 3.1 %

Shares of NASDAQ NATR opened at $13.32 on Thursday. Nature’s Sunshine Products, Inc. has a twelve month low of $10.81 and a twelve month high of $21.72. The firm has a market cap of $249.48 million, a P/E ratio of 15.67 and a beta of 0.87. The company has a 50 day moving average of $13.39 and a 200 day moving average of $15.48.

Nature’s Sunshine Products (NASDAQ:NATR) last announced its quarterly earnings data on Thursday, August 8th. The company reported $0.07 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.18). Nature’s Sunshine Products had a return on equity of 9.79% and a net margin of 3.50%. The firm had revenue of $110.55 million during the quarter.

Wall Street Analyst Weigh In

NATR has been the topic of a number of analyst reports. StockNews.com raised Nature’s Sunshine Products from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, September 10th. DA Davidson dropped their price target on Nature’s Sunshine Products from $23.00 to $21.00 and set a “buy” rating on the stock in a research report on Monday, August 12th. Canaccord Genuity Group initiated coverage on Nature’s Sunshine Products in a research report on Friday, September 13th. They issued a “buy” rating and a $18.00 price target on the stock. Finally, Canaccord Genuity Group began coverage on Nature’s Sunshine Products in a research report on Friday, September 13th. They issued a “buy” rating and a $18.00 price target on the stock.

Hedge Funds Weigh In On Nature’s Sunshine Products

A number of hedge funds have recently added to or reduced their stakes in the company. Skylands Capital LLC raised its stake in Nature’s Sunshine Products by 722.1% during the 2nd quarter. Skylands Capital LLC now owns 333,101 shares of the company’s stock valued at $5,020,000 after buying an additional 292,581 shares during the last quarter. Paradigm Capital Management Inc. NY raised its stake in Nature’s Sunshine Products by 26.8% during the 2nd quarter. Paradigm Capital Management Inc. NY now owns 695,079 shares of the company’s stock valued at $10,475,000 after buying an additional 146,879 shares during the last quarter. Wasatch Advisors LP raised its stake in Nature’s Sunshine Products by 20.6% during the 1st quarter. Wasatch Advisors LP now owns 518,161 shares of the company’s stock valued at $10,762,000 after buying an additional 88,433 shares during the last quarter. American Century Companies Inc. raised its stake in Nature’s Sunshine Products by 25.7% during the 2nd quarter. American Century Companies Inc. now owns 260,479 shares of the company’s stock valued at $3,925,000 after buying an additional 53,221 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in Nature’s Sunshine Products by 4.7% during the 2nd quarter. Dimensional Fund Advisors LP now owns 786,966 shares of the company’s stock valued at $11,860,000 after buying an additional 34,996 shares during the last quarter. 79.40% of the stock is currently owned by hedge funds and other institutional investors.

About Nature’s Sunshine Products

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.